OVERVIEW

Community Practice Connections™ Case Studies in AYA and Adult Acute Lymphoblastic Leukemia - How the Experts Think & Treat is organized by Physicians' Education Resource, LLC (PER).

Release Date: January 31, 2020
Expiration Date: January 31, 2021

Accreditation:
Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Activity Overview:
Community Practice Connections™ Case Studies in AYA and Adult Acute Lymphoblastic Leukemia - How the Experts Think & Treat consists of a series of interactive clinical vignettes, short video interviews of leading experts in leukemia, and short summaries of clinical data related to these issues. The video interviews address decision points in the clinical vignettes, as well as questions commonly faced in the community oncology practice setting.

Benefits of Participating:
• Learn about emerging strategies for patients with relapsed/refractory B-cell acute lymphoblastic leukemia (B-ALL)
• See how experts evaluate and manage measurable/minimal residual disease (MRD)
• Discuss state-of-the-art management of patients with Ph-positive ALL

Learning Objectives:
Upon successful completion of this educational activity, you should be better prepared to:
• Outline risk stratification strategies in ALL to help develop appropriate treatment plans through cytogenetic and immunophenotypic studies
• Evaluate the clinical utility of MRD assessment and how this may inform prognosis and treatment planning for adolescent/young adult populations and adults with ALL
• Define the role of emerging therapies for the management of ALL, including monoclonal antibodies, antibody–drug conjugates, and chimeric antigen receptor T-cell therapies
• Recognize groups of patients who may be eligible for emerging ALL treatment approaches